Table 2.
Univariate and multivariate analyses of overall survival in LSCC patients.
| Clinical variables | Unadjusted P value | Adjusted | |
|---|---|---|---|
| Hazard ratio (95% CI) | P value | ||
| Age | |||
| <60 vs, ≥60 | 0.176 | 1.941 (0.774–4.869) | 0.157 |
| Gender | |||
| Male vs. female | 0.315 | 0.917 (0.112–7.497) | 0.936 |
| Smoking status | |||
| Smokers vs. non-smokers | 0.505 | 0.914 (0.404–2.068) | 0.828 |
| Tumor stage | |||
| T1−T2 vs. T3−T4 | 0.000 | 4.777 (2.040–11.19) | 0.000 |
| Lymph node metastasis | |||
| Absent vs. present | 0.028 | 2.029 (0.247–16.64) | 0.510 |
| TNM stage | |||
| I−II vs. III−IV | 0.022 | 1.464 (0.085–25.13) | 0.793 |
| Differentiation | |||
| Well vs. moderate to poor | 0.167 | 1.147 (0.488–2.696) | 0.754 |
| LncRNA DLEU2 expression | |||
| Low vs. high | 0.001 | 2.985 (1.214–7.341) | 0.017 |
TNM tumor node metastasis, CI confidence interval.